A layer-by-layer (LbL) strategy of modifying an electrode with a specific combination of polymeric and xerogel materials is used to create an effective first generation biosensor for uric acid (UA) -a clinically relevant molecule implemented in pregnancy induced hypertension (PIH) diagnosis, a condition that can lead to a serious disorder called preeclampsia. In addition to offering a new, promising sensor for UA, this study represents significant progress for amperometric biosensor development since the strategy and materials employed were successfully and readily adapted from a glucose biosensor model scheme and used for the effective detection of UA, a fundamentally different molecule compared to glucose. Specifically, each of four, functional modifying layers (outer polyurethane (PU) selective membrane, the inner selective electropolymer, and the xerogel bi-layer) are systematically investigated and tailored for UA permeability and interferent discrimination. The role of PU hydrophobicity and its UA permeability are established while the enzyme-doped and outer diffusional xerogel layers are evaluated for uricase (UOx) species/loading and silane precursor dependence, respectively. LbL systematic evaluation reveals the specific combination of hydroxylmethyl triethoxy silane (HMTES) xerogels, a polyluminol-aniline electropolymer, and 100% hydrophilic polyurethane yields impressive uric acid sensing performance: effective sensitivity (0.8 nA/μM), linear response across physiologically relevant UA concentrations (100-700 μM), fast response times (~ 10 sec), low limits of detection (< 10 μM), and selectivity against most common interferents. Towards the specific application of PIH risk assessment, the optimized sensor exhibited 10 day stability as well as effective shelf-life exceeding 35 days. The presented system rivals or exceeds UA biosensor performance found in the literature and offers the possibility of miniaturization for in situ or in vivo remote diagnostic sensing. The successful adaptation suggests that the strategy and materials may be applicable to detecting/monitoring other medically significant molecules via sensor development.
Introduction
In the biosensor technology field, it is relatively common that individual literature reports focus on systems, strategies, and materials that are selected, designed, and developed for the detection of a very specific target analyte. Over the past two decades, many of these reports have focused specifically on the development of glucose biosensing schemes where a number of excellent reviews are available [1] [2] [3] [4] . The large amount of research activity focused on glucose biosensor development can be attributed to the increasing need for improved diabetes management as well as the idea that glucose represents a well-understood, relatively inexpensive model system for fundamental studies [5] . Within the biosensor research, however, it is relatively rare that the strategies, materials, and constructs shown to be effective for glucose biosensing prove robust and versatile enough to be readily adapted to a dramatically different target molecule. In most cases, such a transition is simply left unexplored. Therefore, a significant development in this area would be the demonstration of a strategy and materials that offer said versatility while maintaining superior performance toward a new target molecule with implications in biomedical application.
Uric acid (UA) is the predominant end product of purine nucleotide catabolism in the human body. UA is present in human blood serum, plasma, urine, and saliva where, due to its poor solubility in biological fluids, it exists predominantly as urate anion at physiological pH [6, 7] . For comparison, in aqueous solutions (20-25ºC) , the solubility of UA (~ 0.0006 g/100 mL) is significantly less than that of glucose (~90 g/100 mL) [7] .
UA imbalances in the body have been linked to many diseases. Elevated levels of UA in blood serum are a significant independent predictor for atherosclerotic cardiovascular disease in high-risk individuals [8] , peripheral artery disease [9] , and chronic kidney disease [10] . Higher concentrations of UA in blood serum have also been shown to be a risk factor for non-alcoholic fatty liver disease [11] and a risk factor for silent brain infarction [12] . Long-standing hyperuricemia also contributes to gout, which is caused by the nucleation and growth of monosodium urate crystals in tissues in and around the joints following the saturation threshold of UA in serum [13] . More recently, UA has also UA-LAYERED.VER25-JEAC-REFS 3 been identified as a key biomarker in wounds, indicating the severity of a wound or presence of infection with increasing concentrations [14] .
Hyperuricemia is also one of the earliest and most consistent observations noted in pregnancy induced hypertension (PIH), a condition that can lead to a dangerous disorder called pre-eclampsia [15] . PIH-related issues are responsible for a five-fold increase in perinatal mortality, 50,000 world-wide deaths per year, and 15% of pre-term births in developing countries. The disorder increases risk to both mothers and infants including: shorter gestation periods, smaller birth weights, premature births, and smallfor-gestational-age infants. The current diagnostic for pre-eclampsia risk is blood pressure measurement as well as laboratory-based analyses of blood and urine protein content (i.e., proteinura). While waiting for blood/urine laboratory results PIH can progressively worsen and raise the risk of pre-eclampsia. The currently accepted medical treatment to relieve pre-eclampsia risk is surgical intervention (i.e., cesarean section) on expectant mothers presenting with hypertension and/or other symptoms of PIH [15] .
Elevated concentrations of UA have been shown to effectively identify a subset of women with PIH who are at greater risk for maternal or fetal morbidities from preeclampsia. A case study by Roberts et al. [15] examined nearly 1000 pregnancies (1997) (1998) (1999) (2000) (2001) (2002) ) with 400 presenting with hypertension and/or proteinuria. The results of the study showed that the highest patient risk group for pre-eclampsia were those displaying hyperuricemia (i.e., above normal UA levels of 0.5 mM) even if they did not initially exhibit hypertension or proteinuria. An effective UA biosensor with the potential for in vitro remote sensing or in vivo operation as an intravenous implant with selectivity and sensitivity to UA between 0.1 and 0.6 mM would accelerate risk assessment of pregnancies, identifying higher risk PIH patients, expediting drug therapy and/or surgical intervention -all of which lower perinatal morality rates and reduce risk to mothers as well as lower treatment cost.
UA biosensing schemes based on amperometric detection have been developed using a range of materials including polymer and self-assembled monolayer modified electrodes as well as electrodes incorporating carbon paste or nanomaterials [16, 17] . Key challenges for the electrochemical approach of UA biosensing remain the selectivity of the schemes for UA in the presence of ascorbic acid as well as achieving effective UA UA-LAYERED.VER25-JEAC-REFS 4 sensitivity at concentrations directly relevant to the real-time measurements. Enzymaticbased biosensors traditionally target the measurement of a specific by-product of its enzymatic reaction as an indirect measurement of the target substrate. Uricase (UOx)-catalyzed reactions of UA: (1) have been employed with direct electrochemical measurement of H 2 O 2 product oxidation [18, 19] or oxygen depletion (1 st generation biosensors) [20] as well as the use of mediator species, which react with H 2 O 2 (2 nd generation biosensors) for the indirect reporting of UA [21, 22] . Recently, Wang and coworkers reported an elegant "smart bandage" UA biosensor capable of indicating UA release from a wound through the detection of H 2 O 2 via Prussian blue mediation with a carbon coating [14] .
One popular strategy for designing amperometric biosensing schemes remains the modification of electrodes with multiple layers of functional materials. This strategy, known as layer-by-layer (LbL) methodology, represents a critical area of sensor design with several recent reviews available to describe both its historical importance as well as more recent progress and future directions [23, 24] . A number of different materials have been incorporated into LbL composite films at electrodes for the purpose of sensor development.
Layering of polyelectrolyte films with enzymes is an important example of one material used for this purpose, including early work with glucose oxidase [25, 26] as well as later work incorporating nanomaterials into layered polyelectrolyte films [27] .
Sol-gels, a gel-like network of polymerized silanes, are another prominent example of a material that has been utilized in LbL design of biosensors with several recent reviews providing an overview summary of the field. [28] [29] [30] Sol-gel materials provide a threedimensional scaffolding for multi-layers of encapsulated enzyme at an electrode. The microencapsulation of enzyme within a sol-gel matrix allows for several well-established advantages, including mild synthetic conditions preserving function/structure of the embedded enzymes, chemical inertness, physical rigidity, negligible swelling in aqueous solutions, thermal/photochemical stability, and synthetically tunable porosity, a property of particular interest for biosensing structures [30] [31] [32] [33] . Over the years, sol-gels, specifically xerogels formed with solvent evaporation, have been extensively explored in the specific UA-LAYERED.VER25-JEAC-REFS [34] . Others have used layer-by-layer (LbL) approaches with sol-gel materials to introduce nanoparticle networks that enhance the signal from glucose sensors [35] . In the context of UA biosensing, Ferreira et al. [36] and Wang et al. [37] reported layering of UOx within polymer films at indium tin oxide and layering of gold nanoparticle-doped choline at glassy carbon electrodes, respectively.
In this report, we present LbL construction of a highly effective 1 st generation amperometric biosensor for UA. While this study stems from prior, proof-of-concept work with a model glucose biosensing system, it represents a significant research advancement of sensing strategy and technology development that it can be adapted to a clinically relevant target. This study presents unprecedented, systematic characterization and evaluation of each functional layer within the sensing scheme. In establishing, for the first time, a thorough understanding of each material comprising these layers, it is shown that the strategy itself can be optimized toward a specific target species other than the glucose model. The results herein suggest that the general strategy as well as systematic variations of the materials involved may allow for strategic design of schemes flexible enough to be adapted toward a variety of target molecules, thereby spawning the development of additional diagnostic sensors. This study culminates with the development and demonstrated performance of a highly functional UA biosensor that features high sensitivity, effective selectivity, and excellent stability attributescollectively an unmatched combination of performance parameters and a system that maintains the potential to be further developed for in vitro or in vivo operation in PIH risk assessment [15] .
Materials and methods

Materials and Instrumentation
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All chemicals were purchased from Sigma-Aldrich unless otherwise specified. were then lysed by sonication, and the cell debris was removed by centrifugation (13,000 rpm, 25 min). The supernatant was added to a Ni-NTA column for purification by affinity chromatography. UOx was bound to the column via a C-terminal 6xHis tag and was extensively washed with 20 mM imidizole prior to elution with 250 mM imidizole.
At this point, the protein was buffer exchanged into 5 mM phosphate, pH 7.0 and lyophilized (Labconco) overnight for long-term storage at -20˚C.
Fabrication and Characterization of the Xerogel Biosensor
Platinum working electrodes were successively polished with 1.0, 0. [5, 35] . SEM and electrochemical characterization of the xerogel layers has been either previously presented [5, 35] or is included in Supplementary Material herein.
Additionally, prior work in the lab evaluated the porosity and surface area of drop-cast
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8 xerogel films, including films from silane precursors used in this report, using electrochemistry, spectroscopy, and contact angle goniometry. [5] In order to apply the 1:10 polyluminol:polyaniline (PL-A) layer, a previously discovered procedure was used that is known to provide selectivity for UA sensing [38, 39] . The xerogel-modified electrode described above was immersed in 25 The outer polyurethane (PU) layer semipermeable membrane was applied as previously reported [5, 34, 35] . Briefly, PU blends were prepared from dissolving different ratios of HPU and TPU in ethanol and THF, which was stirred overnight. A 10.0 μL aliquot of the PU blend was then deposited on the bare or xerogel modified electrode and allowed to dry (ambient, 30 min.).
Evaluation of Sensor Performance
As in previous work [5, 34, 35] , assembled sensors were pre-treated by being soaked in PBS (65.55mM; pH=7) for 1 hour to ensure saturation of the xerogel matrix.
The sensors then were immersed in 25 mL of stirred PBS (65.55 mM; pH=7) for amperometric measurements wherein the working electrode potential was held at +0.65 V (vs. Ag/AgCl, satrd' KCl) for 20 min before successive 25 μL injections of 50 mM UA solution at 200 s intervals and the I-t curve was collected. Sensor sensitivity to UA was determined via linear regression analysis of calibration curves for the sensor current response at increasing UA concentrations. As in previous studies [5, 34, 35] , a conservative estimate of sensor response time (t r-95% ), time before 95% of total response recorded, was employed. As previously described [5, 34, 35] , film permeability was measured via permeability indices (PI) using the following equation:
where film and bare are the measured changes in current for a species at a filmmodified and bare electrode, respectively. As previously described in biosensing literature, amperometric selectivity coefficients (K amp ) were used to evaluate interferent responses and were calculated using the following equation:
where j and UA are the measured currents for a specific interferent species (j) and UA at concentrations of C j and C UA , respectively [34, 35, 40] . If necessary, sensors were stored at 4-7° C immersed in PBS (65.55 mM; pH 7).
Results and discussion
The general design of the layer-by-layer (LbL) biosensing scheme originally developed and demonstrated for a glucose sensing model system [5] is depicted in Scheme I and features four functional layers modifying a platinum electrode: (1) an enzyme-doped xerogel layer; (2) a diffusion-limiting xerogel layer; (3) an inner selective electropolymer layer; and (4) an outer-selective polyurethane layer. The enzymatic reaction occurs in the lowest layer, the enzyme-doped xerogel, where peroxide is produced and oxidized at the electrode, indirectly indicating the presence of the substrate species. This specific combination of layering was used to successfully create an effective glucose sensor and prompted strategic exploration adapting the scheme to other targets of interest, in this case, UA biosensing. With the exception of the electropolymer layer, which is specifically developed elsewhere [39] , each material comprising the layers was systematically investigated and optimized to UA detection. Beyond layer optimization, composite films were evaluated on sensing performance, including sensitivity, response time, selectivity, stability, and shelf-life.
Outer Selective Polyurethane Membrane
The semi-permeable polyurethane layer (PU) controls the diffusion of analyte (i.e., UA) and oxygen into the composite film, while also providing some selectivity based on its hydrophobic character [34] . The PU mixture used in previous sensing glucose biosensing schemes was a 50:50 blend of hydrophilic polyurethane (HPU) and hydrophobic polyurethane (TPU) [5, 34] . To specifically evaluate and optimize the PU for UA biosensing, however, several experiments were conducted on a series of electrodes coated with different ratios of HPU:TPU blends: 100:0, 75:25, 50:50, 25:75, and 0:100.
Voltammetry and amperometry were used to assess the PU layer's hydrophobic and blocking characteristics as well as its permeability to H 2 O 2 and UA -components critical to the proposed sensing scheme.
Observational experiments probing the PU interface hydrophobicity and porosity utilized cyclic voltammetry of a potassium ferricyanide (FeCN) at each film type. UA itself, while electroactive, exhibits voltammetry not pronounced enough at bare or modified platinum electrodes for direct assessment at most modified electrodes [41] .
FeCN voltammetric probing proved an effective tool to learn about the electrode interfaces. Figure 1A displays FeCN voltammetry at various PU films on platinum compared to that at a bare platinum electrode. The addition of any PU layers significantly decreases the voltammetric signature of FeCN, exhibiting drastically lower current. A closer look at the voltammetry at the PU films (Fig. 1A , inset) reveals a significant trend whereby voltammetry of FeCN, acting as an UA mimic, is most significant at the 100% HPU interface (Fig. 1A, b) , subsequently fades as the hydrophobic (TPU) component is increased (Fig. 1A, b→e) , and is completely blocked at the most hydrophobic, 100% TPU interface (Fig. 1A, f) . These results suggest that the PU layer most conducive to UA sensing would be the 100% HPU coating, which also shows a substantial difference in the morphology from the 100% TPU according to SEM and AFM microscopy (Supplementary Material).
Identical PU interfaces were also tested for amperometric response toward H 2 O 2 .
PU-coated electrodes and a bare platinum electrode were held at +0.65 V during successive injections of H 2 O 2 , generating current-time (I-t) curves. The results ( Figure   1B ) reiterate the FeCN voltammetry findings that with the addition of any PU layer, the overall signal is diminished but the most hydrophilic layer, 100% HPU (Fig. 1B,b The most significant role of the outer selective PU membrane is the amperometric current generated via direct injections of UA as a function of the composition of HPU versus TPU in a modified electrode poised at +0.65 V. Since UA is electroactive, any signal generated from its direct oxidation is due to the molecule gaining access to the electrode through the PU layer. UA amperometry at various PU modified electrodes should reveal the most conducive PU combination for UA to permeate the PU layer (Figure 2) . Results again show that with any PU modification there is significant UA electrochemistry blockage, but the observed amperometric response is greatest with PU layers possessing higher HPU components.
As an additional evaluation of the PU membrane, permeability of UA, common endogenous interferents (glucose, oxalic acid, sodium nitrite), and artificial interferents (acetaminophen, ascorbic acid) was assessed. In this study, glassy carbon electrodes (GCE), which exhibit greater voltammetric response toward UA than platinum electrodes, were implemented to isolate effective evaluation of the PU layer [39] . GCEs were modified with different blends of PU were subjected to amperometry (+0.65 V) with injections of UA and the aforementioned interferent species. Permeability indices or PI (see Experimental Details) were calculated for each species and found to be negligible for some interferents (i.e., oxalic acid, glucose, and sodium nitrate yielded no significant amperometric response at any of the films). PI values for acetaminophen, ascorbic acid, and UA as well as ratios for UA-to-acetaminophen and UA-to-ascorbic acid PI values were also tabulated (Supplementary Material). The results again suggest higher HPU content in the PU films (75:25 and 100:0) are most conducive for UA signal and provide reasonable interferent discrimination. Based on the collective findings of these experiments, the PU layer was optimized for UA sensing implementing 100% HPU as the outer selective membrane.
Inner Selective Electropolymer Membrane
The electropolymer layer serves as a critical semi-permeable membrane, providing selectivity through common interferent discrimination. As mentioned previously, the systematic design and identification of the electropolymerized layer utilized for the LbL UA sensing strategy was extensively developed and reported elsewhere [39] . An effective polymer layer providing selectivity against interferents (e.g., ascorbic acid, sodium nitrite, glucose, and oxalic acid) was found to be a 1:10 mixture of polyluminol-to-polyaniline. As described in the Experimental Section, the polyluminolpolyaniline (PL-A) layer is electropolymerized on the modified electrodes following xerogel bi-layer (see below) formation.
Xerogel Bi-layer
The effective functionality as seen in prior findings from this lab and others [5, 34] . It should be noted that physical characterization of different xerogel materials (i.e., gels formed formed from varying silane precursors), including SEM and electrochemical characterization as well as porosity/surface area assessment, have been performed prior to this study [5, 35] or are included as part of the Supplementary Material in this report.
As an initial study of the xerogel layers, the first layer housing the UOx enzyme was examined. Specifically, the influence of UOx enzyme species toward UA sensitivity within an octyl-trimethoxysilane (OTMS) xerogel a matrix previously determined to be suitable for these schemes, was investigated. Sensors were constructed with different species of UOx in the first layer of OTMS followed by a second layer OTMS without UOx and capped with PU (100% HPU). To evaluate UOx activity and sensitivity, the inner selective electropolymer film was not applied in these systems as its primary purpose is selectivity. Three types of sensors were created, each featuring a different UOx species, including Bacillus fastidiosus and Candida sp, as well as, Bacillus fastidiosus produced in-house from codon-optimized expression in Escherichia coli.
Each system was subjected to successive injections of UA standard while the amperometric I-t response was recorded (not shown) and translated into calibration curves ( Figure 3A) with acceptable linear range. The results suggest that the in-house optimized Bacillus fastidiosus enzyme is able to achieve significant sensitivity (i.e., slope) and defined step responses across the relevant UA concentration range (i.e., 100-600 μM) at a significantly lower operating cost compared to commercially available sources of the enzyme. Similar calibration curves for systems featuring each of the enzyme species embedded in xerogels with and without PU capping layer were achieved as well (see Supplementary Materials). Based on these comparisons, the remainder of the study was conducted with the in-house Bacillus fastidiosus UOx.
The loading (i.e., the doping level) of UOx within the first xerogel layer was explored. Composite films of OTMS xerogel bi-layers with and without the PU capping layer were formed with different amounts (3, 6, and 9 mg) of UOx doped into the first xerogel layer and their amperometric response to successive UA injections was monitored. The results suggest that greater UOx concentrations were not beneficial to performance (Supplementary Material). That is, UA sensitivity was not improved with higher UOx doping levels in the xerogel. As such, subsequent UOx-doped xerogels in the study were prepared with only 3-4 mg of UOx. In enzyme-based biosensing schemes, it is thought that higher concentrations of certain enzymes permit the rate of substrate conversion to become independent of enzyme concentration [34] . The linearity of the results of the calibration curves, both in testing the enzyme species and loading as well as in subsequent calibration curves to be presented, suggests that the 3-4 mg UOx doping level within the xerogels represents an excess of available UOx and allows the system to avoid saturation effects that cause non-linearity and calibration curve plateau which would necessitate Michaelis-Menton kinetic measurements [42, 43] . Additionally, the linear response overlaps well with the relevant physiological concentration range of UA, suggesting that UOx activity is not a factor in these sensing schemes. Similar linearity is observed in all subsequent measurements of LbL assemblies that show promise for UA sensor development.
Ionic strength (μ) of the sample matrix is particularly important to evaluate given the goals of eventually using these findings toward in-vitro, remote bedside sensors or invivo implantable devices for continuous UA monitoring. Electrochemical sensing is dependent on solution activity rather than simple concentration, making evaluation of the sensor at biological levels of μ an important facet of the sensor development. OTMS bilayer systems were used to evaluate μ dependence of the sensor response to UA, again without incorporating the selectivity-based electropolymer layer. Calibration curve data for UA response of the Pt/OTMS*/OTMS/PU system was collected at different concentrations of phosphate buffer solution (4.4-250 mM PBS at pH~7) which differ significantly in ionic strength as well (10 < μ < 572 mM) -see Supplementary Material.
The UA sensitivity of the composite film seems to increase with μ to a point (65.55 mM; μ 150 mM) before plateauing at even higher values (Supplementary Material). Given the sensitivity found at 65.55 mM PBS (μ 150 mM) and its similarity to the μ of blood plasma (145 mM) [44] , all subsequent experiments were conducted in 65.55 mM PBS.
Optimization of enzyme species, loading, and ionic strength, prompted investigation into the silane precursor utilized in forming the xerogel layers. It should be noted that the sensor designs discussed herein utilize xerogel bi-layers derived from the same silane precursor -a homogeneous xerogel bi-layer. Heterogeneous xerogel bi-layer systems, where each layer of the xerogel is derived from a different silane precursor, were extensively studied in the glucose model system and showed convincing results that no gain in either sensitivity or selectivity could be achieved by using different types of 
Uric Acid Sensing Performance -Complete System
With each layer optimized for UA permeability and sensitivity, performance of the complete sensor (i.e., xerogel bi-layer, electropolymer membrane, and PU capping layer) was evaluated. Sensor sensitivity, selectivity, response time, stability, and shelflife were assessed for the most promising schemes: xerogel bi-layers of HMTES, OTMS, IBTMS, and PTMS capped with both inner selective PL-A, and outer selective 100%
HPU membranes (Scheme I). Figure 4A shows the calibration curves of all four systems with comparable sensitivity toward UA (~0.6-1.0 nA/μM), a result paralleling the previous systems tested without the PL-A electropolymer layer (Fig. 3B) . All of the systems maintained excellent linear ranges with stair-step responses across the physiologically relevant range of UA concentration (100 to 700 μM linear and dynamic ranges). In addition, and with the exception of the film using PTMS, all showed average response times of ≤ 10 seconds toward UA. All of the films showed very low limits of detection (LOD) as well though, in this case, the parameter is less critical than analyte sensitivity within the physiologically relevant range. A complete table summary of the performance properties for the four complete systems is provided ( Table 1 ) and a comparison of these properties to other literature reports of uric acid biosensors is provided in the Supplementary Materials as well.
A critical biosensor characteristic is selectivity for the targeted analyte in the presence of common interferents. While the use of an enzymatic reaction allows for a certain level of natural selectivity [1] , some species can still be problematic particularly given the relatively high potential used to oxidize H 2 O 2 . In the case of UA biosensing, acetaminophen, ascorbic acid, sodium nitrite, oxalic acid, and glucose are considered interferents [16] . Figure 4B provides amperometric I-t curves during injections of UA and common interferents at the full HMTES xerogel system which was determined to
give the highest UA sensitivity (Fig. 4A) . Acetaminophen yielded the only significant response while UA exhibited concentration sensitive responses (100 μM and 300 μM UA, Fig. 4B ) in the presence of the interferents. This qualitative selectivity assessment from I-t curves can be quantitatively described by measuring selectivity coefficients for each interferent compared to UA (Experimental Details) [5, 34] . Figure 4C displays the comparison of selectivity coefficients for the HMTES, OTMS, IBTMS and PTMS full sensors. Positive coefficients indicate that selectivity for a specific species while negative coefficients suggest the species is sufficiently discriminated against. Two key findings are suggested by the results. First, while all the systems give effective sensitivity toward UA, the HMTES and OTMS systems were most UA selective.
Second, while the full composite film effectively discriminates against most common intererents, acetaminophen, a pain-relieving synthetic drug that is commonly prescribed as safe for pregnant women [45] , remains problematic and is discussed further below. Figure 5 shows the results of a more focused investigation of the HMTES full sensing system, determined to be the most effective optimized system tested in terms of both UA sensitivity and interferent discrimination (Fig. 4) . each other to achieve the observed sensing performance at the expense of signal magnitude. That is, the full system has the lowest current response for UA (Fig. 5C) largely because the final two ad-layers (i.e., outer xerogel diffusion-limiting layer and outer polyurethane layers) provide a diffusional limitation toward interfering species at the expense of UA signal. While dampening the signal, these layers provide physical stability and electrode-to-electrode consistency, insulating the current response from variations in enzyme loading. These layers appear to regulate the diffusion of UA substrate to the enzyme as evidenced by the absence of saturation behavior in the calibration curves over the targeted concentration range, a result suggesting mixed kinetic and diffusional control of the signal production [42] . Strategies for enhancing the magnitude of the signal in these film systems are currently being explored.
For a sensing model to be effective stability during use and shelf-life during storage must be considered. Sensors should maintain stability (sensitivity, response time) and selectivity toward the analyte over a period of time relevant to its intended application. These UA sensors were monitored for ten days, significantly longer than typical pre-birth stays of PIH-suspected pregnant mothers. Similarly, the shelf-life of the sensors was tested. In these experiments, numerous sensors were created and tested in a single day (day 0) before being stored for a maximum of 30 days. At regular intervals, different sets of stored sensors were tested for sensitivity, response time, and selectivity. response time, linear/dynamic range, limit of detection, and stability and the additional aspects studied here. For example, the current study examines, in detail, the selectivity against common interferents. This is an important sensing parameter that was not even referenced in some studies [22] or showed poor discrimination against ascorbic acid in others [20] , an interferent completely eliminated in the biosensor presented here. While acetaminophen interference does remains an issue that we continue to investigate, it can be practically managed during UA monitoring with the sensor in conjunction with recording accurate patient history to determine drug ingestion six hours prior to measurement [46] . The current study also includes an assessment of the UA biosensor shelf-life, a property not addressed in any of the comparison literature.
Conclusions
This study represents an unprecedented and detailed evaluation of the functionality of each material in a LbL biosensing scheme and presents a viable UA sensor that may be later miniaturized into biomedical devices for in vivo implantation or real-time in-vitro measurement for PIH detection/monitoring [47, 48] . The functional layering of UOx-doped and un-doped xerogel material, the selective electropolymerized PL-A, and optimized PU membrane work in concert as an effective UA biosensor that is poised for further development, perhaps incorporated on an intravenous wire/needle electrode, for example [34, 49] . A second aspect of this study to note is the successful adaptation of the LbL xerogel-based sensing scheme developed from the glucose model system [5, 34, 35 ] to a new and separate target molecule of clinical relevance [15] . The presented work suggests that each layer serves a function and can be methodically optimized toward target species. In context, the work seemingly provides a broad spectrum biosensing strategy able to be deliberately applied to specific biomedical needs
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in the area of diagnostic tools that can save time, lower expense, and maintain patient health (e.g., cholesterol [50] and galactose sensor development [51] . 
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